Highlights of prescribing information: ELIGARD (leuprolide acetate) suspension for subcutaneous injection, Part 2

HERO ID

4121223

Reference Type

Technical Report

Year

2014

HERO ID 4121223
Year 2014
Title Highlights of prescribing information: ELIGARD (leuprolide acetate) suspension for subcutaneous injection, Part 2
Authoring Organization Tolmar Therapeutics, Inc.
City Bridgewater, NJ
Is Certified Translation No
Dupe Override No
Comments ICF NOTE: 2301-NMP-45.pdf
Is Public No
Is Qa No